Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,580 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $454.19 | 4 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $252.48 | 3 | $0 (2018) |
| Relypsa, Inc. | $206.45 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $123.80 | 1 | $0 (2017) |
| Horizon Pharma plc | $123.43 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $120.73 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $110.00 | 1 | $0 (2017) |
| Amgen Inc. | $103.63 | 1 | $0 (2021) |
| Vifor Pharma, Inc. | $85.45 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $311.08 | 3 | Novo Nordisk Inc ($122.00) |
| 2019 | $329.50 | 3 | Janssen Pharmaceuticals, Inc ($120.73) |
| 2018 | $321.08 | 3 | Novo Nordisk Inc ($218.45) |
| 2017 | $618.50 | 6 | SANOFI-AVENTIS U.S. LLC ($149.85) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: Diabetes | ||||||
| 07/13/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $103.63 | General |
| Category: Inflammation | ||||||
| 06/25/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $85.45 | General |
| Category: Hyperkalemia | ||||||
| 12/05/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $120.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $95.03 | General |
| Category: Hyperkalemia | ||||||
| 04/25/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $113.74 | General |
| Category: Obesity | ||||||
| 06/28/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $122.12 | General |
| Category: Diabetes | ||||||
| 06/04/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $96.33 | General |
| Category: Diabetes | ||||||
| 05/18/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $102.63 | General |
| Category: DIABETES | ||||||
| 12/28/2017 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $123.43 | General |
| Category: KRYSTEXXA | ||||||
| 09/28/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $123.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $94.91 | General |
| Category: DIABETES | ||||||
| 06/01/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/18/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $54.94 | General |
| Category: DIABETES | ||||||
| 05/05/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $111.42 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 47 | 53 | $5,884 | $1,847 |
| 2021 | 2 | 51 | 55 | $7,400 | $2,500 |
| 2020 | 2 | 85 | 98 | $12,949 | $2,711 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 42 | $4,872 | $1,588 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 11 | 11 | $1,012 | $259.10 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 20 | $3,340 | $1,274 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 32 | 35 | $4,060 | $1,225 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 58 | 67 | $7,772 | $1,760 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 31 | $5,177 | $950.97 | 18.4% |
About Dr. Joan Zinkawich, MD
Dr. Joan Zinkawich, MD is a Internal Medicine healthcare provider based in Londonderry, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770626335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joan Zinkawich, MD has received a total of $1,580 in payments from pharmaceutical and medical device companies, with $311.08 received in 2021. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,580).
As a Medicare-enrolled provider, Zinkawich has provided services to 183 Medicare beneficiaries, totaling 206 services with total Medicare billing of $7,058. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Londonderry, NH
- Active Since 02/14/2007
- Last Updated 11/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770626335
Products in Payments
- Veltassa (Drug) $291.90
- SOLIQUA (Drug) $252.48
- BYDUREON (Drug) $123.80
- KRYSTEXXA (Drug) $123.43
- Tresiba (Drug) $122.12
- RYBELSUS (Drug) $122.00
- INVOKANA (Drug) $120.73
- Saxenda (Drug) $113.74
- ENTRESTO (Drug) $110.00
- Otezla (Drug) $103.63
- Xultophy 100/3.6 (Drug) $96.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Londonderry
Donald Rainone, M.d, M.D
Internal Medicine — Payments: $1.5M
Dr. Laura Horton, M.d, M.D
Internal Medicine — Payments: $668.01
Dr. Ahmad Usmani, M.d, M.D
Internal Medicine — Payments: $633.52
Dr. Pamela Stamegna, M.d, M.D
Internal Medicine — Payments: $98.70
Andrew Rosen, Md, MD
Internal Medicine — Payments: $21.70
Heather Mane, M.d, M.D
Internal Medicine — Payments: $21.70